Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

14 dic 2017 10:00 a.m. - 14 dic 2017 11:00 a.m.

(Eastern Standard Time)

Online

Complimentary - Getting to Approval Faster Through Technology Innovation

Perspectiva general

This Solution Provider Webinar is brought to you by DIA in cooperation with


Microsoft       Parexel       Allergan

The last 40 years has seen a technology revolution across all aspects of society, yet in that period, the cost and time to bring life-saving therapies to patients has only increased. In this round table discussion, we discuss the factors that have led to this state of affairs, and show how new innovations in areas such as AI, combined with existing investments in processes and technology, can finally reverse the trend.

Continuing Education Credits are not available for this event.

Temas destacados

  • Regulatory Affairs
  • Process optimization
  • Artificial Intelligence and common data platforms

¿Quiénes deben asistir?

Professionals who work in the area of:
  • Regulatory Operations
  • Regulatory Affairs
  • Chemistry, Manufacturing, and Controls
  • Operations
  • Safety
  • Clinical
  • Development Operations
  • Pre-Clinical
  • Legal
  • Compliance
  • Executive Leadership
  • Information Technology
  • Document Management
  • Biostatistics
  • Clinical Data Management

Objetivos de aprendizaje

At the conclusion of this webinar, participants should be able to:
  • Describe factors that lead to inefficiencies in the drug discovery and development process
  • Describe new technologies that will remove those inefficiencies
  • Describe simplified powerful architectures designed to enhance specialized regulatory systems
  • Recognize how the organizations will be simplified as tools merge and become more intuitive

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.